NCT02215772View on ClinicalTrials.gov

Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2008

Conditions
Healthy
Interventions
DRUG

BI 44370 BS

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY